194 related articles for article (PubMed ID: 8661409)
1. Variability of herpes simplex virus 1 gL and anti-gL antibodies that inhibit cell fusion but not viral infectivity.
Novotny MJ; Parish ML; Spear PG
Virology; 1996 Jul; 221(1):1-13. PubMed ID: 8661409
[TBL] [Abstract][Full Text] [Related]
2. A heptad repeat in herpes simplex virus 1 gH, located downstream of the alpha-helix with attributes of a fusion peptide, is critical for virus entry and fusion.
Gianni T; Menotti L; Campadelli-Fiume G
J Virol; 2005 Jun; 79(11):7042-9. PubMed ID: 15890943
[TBL] [Abstract][Full Text] [Related]
3. Structure-function analysis of herpes simplex virus glycoprotein B with fusion-from-without activity.
Roller DG; Dollery SJ; Doyle JL; Nicola AV
Virology; 2008 Dec; 382(2):207-16. PubMed ID: 18950828
[TBL] [Abstract][Full Text] [Related]
4. Human herpesvirus-6 glycoprotein H and L homologs are components of the gp100 complex and the gH external domain is the target for neutralizing monoclonal antibodies.
Liu DX; Gompels UA; Foa-Tomasi L; Campadelli-Fiume G
Virology; 1993 Nov; 197(1):12-22. PubMed ID: 7692666
[TBL] [Abstract][Full Text] [Related]
5. The identification and characterization of fusogenic domains in herpes virus glycoprotein B molecules.
Galdiero S; Vitiello M; D'Isanto M; Falanga A; Cantisani M; Browne H; Pedone C; Galdiero M
Chembiochem; 2008 Mar; 9(5):758-67. PubMed ID: 18311743
[TBL] [Abstract][Full Text] [Related]
6. Characterization of glycoprotein C of HSZP strain of herpes simplex virus 1.
Oravcová I; Kúdelová M; Mlcuchová J; Matis J; Bystrická M; Westra DF; Welling-Wester S; Rajcáni J
Acta Virol; 2000 Apr; 44(2):99-108. PubMed ID: 10989701
[TBL] [Abstract][Full Text] [Related]
7. Passive transfer of anti-herpes simplex virus type 2 monoclonal and polyclonal antibodies protect against herpes simplex virus type 1-induced but not herpes simplex virus type 2-induced stromal keratitis.
Ritchie MH; Oakes JE; Lausch RN
Invest Ophthalmol Vis Sci; 1993 Jul; 34(8):2460-8. PubMed ID: 8392037
[TBL] [Abstract][Full Text] [Related]
8. The gH-gL complex of herpes simplex virus (HSV) stimulates neutralizing antibody and protects mice against HSV type 1 challenge.
Peng T; Ponce-de-Leon M; Jiang H; Dubin G; Lubinski JM; Eisenberg RJ; Cohen GH
J Virol; 1998 Jan; 72(1):65-72. PubMed ID: 9420201
[TBL] [Abstract][Full Text] [Related]
9. Epitope mapping of herpes simplex virus type 2 gH/gL defines distinct antigenic sites, including some associated with biological function.
Cairns TM; Shaner MS; Zuo Y; Ponce-de-Leon M; Baribaud I; Eisenberg RJ; Cohen GH; Whitbeck JC
J Virol; 2006 Mar; 80(6):2596-608. PubMed ID: 16501070
[TBL] [Abstract][Full Text] [Related]
10. Characterization of gamma2-human herpesvirus-8 glycoproteins gH and gL.
Naranatt PP; Akula SM; Chandran B
Arch Virol; 2002 Jul; 147(7):1349-70. PubMed ID: 12111412
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibodies to the distinct antigenic sites on glycoproteins C and B and their protective abilities in herpes simplex virus infection.
Bystrická M; Petríková M; Zatovicová M; Soláriková L; Kostolanský F; Mucha V; Russ G
Acta Virol; 1997 Feb; 41(1):5-12. PubMed ID: 9199708
[TBL] [Abstract][Full Text] [Related]
12. Differences in the role of glycoprotein C of HSV-1 and HSV-2 in viral binding may contribute to serotype differences in cell tropism.
Gerber SI; Belval BJ; Herold BC
Virology; 1995 Dec; 214(1):29-39. PubMed ID: 8525631
[TBL] [Abstract][Full Text] [Related]
13. Human antibodies to herpes simplex virus type 1 glycoprotein C are neutralizing and target the heparan sulfate-binding domain.
Adamiak B; Trybala E; Mardberg K; Johansson M; Liljeqvist JA; Olofsson S; Grabowska A; Bienkowska-Szewczyk K; Szewczyk B; Bergstrom T
Virology; 2010 May; 400(2):197-206. PubMed ID: 20176392
[TBL] [Abstract][Full Text] [Related]
14. Growth, spread, and extracellular localization of herpes simplex virus 1 in Vero cells in the presence of an anti-gD plaque inhibiting monoclonal antibody.
Mannini-Palenzona A; Costanzo F; Fiorilli MP; Derenzini M
New Microbiol; 1998 Jan; 21(1):65-76. PubMed ID: 9497931
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica.
Roehrig JT; Bolin RA; Kelly RG
Virology; 1998 Jul; 246(2):317-28. PubMed ID: 9657950
[TBL] [Abstract][Full Text] [Related]
16. Neuroinvasive properties of herpes simplex virus type 1 glycoprotein variants are controlled by the immune response.
Mitchell BM; Stevens JG
J Immunol; 1996 Jan; 156(1):246-55. PubMed ID: 8598469
[TBL] [Abstract][Full Text] [Related]
17. Identification of the fusion-from-without determinants of herpes simplex virus type 1 glycoprotein B.
Saharkhiz-Langroodi A; Holland TC
Virology; 1997 Jan; 227(1):153-9. PubMed ID: 9007068
[TBL] [Abstract][Full Text] [Related]
18. The pro-fusion domain of herpes simplex virus glycoprotein D (gD) interacts with the gD N terminus and is displaced by soluble forms of viral receptors.
Fusco D; Forghieri C; Campadelli-Fiume G
Proc Natl Acad Sci U S A; 2005 Jun; 102(26):9323-8. PubMed ID: 15972328
[TBL] [Abstract][Full Text] [Related]
19. Modified entry and syncytium formation by herpes simplex virus type 1 mutants selected for resistance to heparin inhibition.
Pertel PE; Spear PG
Virology; 1996 Dec; 226(1):22-33. PubMed ID: 8941319
[TBL] [Abstract][Full Text] [Related]
20. Replacement of glycoprotein B gene in the herpes simplex virus type 1 strain ANGpath DNA by that originating from nonpathogenic strain KOS reduces the pathogenicity of recombinant virus.
Kostál M; Bacík I; Rajcáni J; Kaerner HC
Acta Virol; 1994 Apr; 38(2):77-88. PubMed ID: 7976866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
